FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutical solutions, in particular to methods for lyophilising an aqueous solution of thrombin, solutions for use in such lyophilisation processes and to solid thrombin compositions. Method for lyophilising an aqueous solution of thrombin comprises the preparation of an aqueous solution of thrombin, containing from 1 to less than 4.6 % (w/v) saccharide or sugar alcohol; from at least 0.7 to less than 1.75 % (w/v) sodium chloride; from 0.2 to 3 % (w/v) albumin; 0.3 to 1.5 % (w/v) calcium chloride; and from 0.14 to 1 % (w/v) sodium acetate; and free of polyethylene glycol, and lyophilisation of the aqueous solution of thrombin, wherein the level of the aqueous solution of thrombin in the lyophilisation vessel is in the range of 6 mm to 10 mm, and the total lyophilisation time is not more than 35 hours. Solid composition for stopping bleeding obtained by this method is also disclosed.
EFFECT: group of inventions provides stable solid compositions with a low water content and high thrombin activity upon reconstitution.
30 cl, 1 dwg, 9 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL STABILISER FOR PHARMACEUTICAL PROTEINS | 2011 |
|
RU2571496C2 |
DRY COMPOSITION FOR USE IN HAEMOSTASIS AND WOUND HEALING | 2015 |
|
RU2715235C2 |
NOVEL STABILIZER FOR PHARMACEUTICAL PROTEINS | 2011 |
|
RU2707090C2 |
LYOPHILIZED PHARMACEUTICAL COMPOSITIONS | 2016 |
|
RU2723590C2 |
PIPERACILLIN AND TAZOBACTAM-CONTAINING COMPOSITIONS USED FOR INJECTION | 2004 |
|
RU2322980C2 |
LYOPHILIZED LIPOSOMES | 2012 |
|
RU2780489C2 |
STABILISED SOLID COMPOSITIONS OF VII FACTOR POLYPEPTIDES | 2003 |
|
RU2366451C2 |
DRY COMPOSITION OF TRANSGLUTAMINE | 2009 |
|
RU2616847C2 |
METHODS, COMPOSITIONS AND SETS FOR LYOPHILISATION | 2010 |
|
RU2540480C2 |
LIOPHILIZED LIPOSOMES | 2012 |
|
RU2648753C2 |
Authors
Dates
2018-10-26—Published
2013-11-28—Filed